Type of all surgical complications (n = 240) | n | % | % 90-day mortality |
---|---|---|---|
No surgical complications | 169 | 70.4 | 3 |
PF B or C | 28 | 11.7 | 25 |
PF B or C and bleeding | 8 | 3.3 | 62.5 |
Bleeding in the intestines | 2 | 0.8 | 0 |
Intraabdominal bleeding – no PF | 4 | 1.7 | 25 |
Bile leak | 10 | 4.2 | 0 |
Leak from GEA | 5 | 2.1 | 20 |
Dehiscence of laparotomy | 3 | 1.3 | 0 |
Intraabdominal abscess | 6 | 2.5 | 0 |
Ileus | 1 | 0.4 | 0 |
Thrombosis of vascular graft | 2 | 0.8 | 0 |
Volvulus coeci | 1 | 0.4 | 0 |
Stenosis of coeliac trunk | 1 | 0.4 | 0 |
P1 (n/%) | P2 (n/%) | All (n/%) | p | ||
---|---|---|---|---|---|
male | 51 | 80 | 131 | ||
53.1% | 55.6% | 54.6% | |||
0.4 | |||||
female | 45 | 64 | 109 | ||
46.9% | 44.4% | 45.4% | |||
Mean (years) | 66.1 ± 9.9 | 65.98 ± 10.1 | 66.4 | 0.91 | |
1 | 17 | 43 | 17 | ||
17.7% | 29.9% | 17.7% | |||
2 | 53 | 68 | 53 | 0.103 | |
55.2% | 47.2% | 55.2% | |||
3 | 26 | 33 | 26 | ||
27.1% | 22.9% | 27.1% | |||
4 | 32 | 36 | 0.0001 | ||
22.2% | 15.0% | ||||
Mean (days) | 21.2 ± 14.5 | 19 ± 11.6 | 19.8 | 0.138 | |
Mean (mmol/l)(mmol/l) | 67.6 ± 71.5 | 79.0 ± 85.5 | 74.7 | 0.028 | |
34 | 51 | 85 | 0.554 | ||
35.4% | 35.4% | 35.4% | |||
PD | 92 | 115 | 207 | ||
95.8% | 79.9% | 86.3% | 0.0001 | ||
TP | 4 | 29 | 33 | ||
4.2% | 20.8% | 14.2% | |||
12 | 28 | 40 | 0.17 | ||
12.5% | 19.4% | 16.7% | |||
Direct suture | 10 | 14 | 24 | ||
10.4% | 9.7% | 10.0% | 0.043 | ||
Vascular graft | 2 | 14 | 16 | ||
2.1% | 9.7% | 6.7% | |||
34 | 55 | 89 | 0.383 | ||
38.2% | 37.1% | ||||
7 | 5 | 12 | 0.152 | ||
3.5% | 5.0% | ||||
11 | 8 | 19 | 0.080 | ||
5.6% | 7.9% |
N | OAC | P | ASC | P | BC | P | OL | P | AA | P | PL | P | AGC | P | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
240 | No compl. | 65.3 ± 10.3 | 0.051 | 66.2 ± 10 | 0.452 | 66 ± 10 | 0.665 | 65 | 0 056 | 65.7 ± 10 | 0.256 | |||||
Compl. | 67.9 ± 9.1 | 63.5 ± 12 | 67.1 ± 8 | 73 | 67.3 ± 8 | |||||||||||
240 | <70 | 28.6% | 23.8% | 0.071 | 8.6% | 0.094 | 4.8% | 0.369 | 16.3% | 0.234 | ||||||
>69 | 43.7F% | 33.3% | 3.7% | 6.7% | 21.4% | |||||||||||
240 | ASA 1+2 | 5.5% | 0.465 | 5.5% | 0.465 | 0.457 | ||||||||||
ASA 3 | 6.8% | 6.8% | ||||||||||||||
240 | No compl. | 70.1 ± 74 | 0.271 | 68.3 ± 73.6 | 0.062 | 74.4± 78 | 0.969 | 0.231 | 68.1 ± 70 | 0.195 | ||||||
Compl. | 82.9 ± 89 | 89.5 ± 93.1 | 75.5 ± 108 | 91.4 ± 99 | ||||||||||||
240 | No EBD | 33.5% | 0.082 | 24.5% | 5.8% | 0.594 | 7.1% | 0.203 | 0.640 | 11.6% | 0.092 | |||||
EBD | 43.5% | 37.6% | 5.9% | 3.5% | 18.8% | |||||||||||
240 | PD | 37.2% | 0.545 | 29.5% | 0.488 | 6.3% | 0.400 | 5.8% | 0.600 | - | - | 13% | 0.126 | |||
TP | 36.4% | 27.3% | 3% | 6.1% | 21.2% | |||||||||||
240 | No vasc. | 39.5% | 0.115 | 30.0% | 0.334 | 4.5% | 0.063 | 6% | 0.578 | 0.738 | 21.1% | 0.083 | ||||
Vasc. resect. | 27.5% | 25.0% | 12.5% | 5% | 7.7% | |||||||||||
201 | No compl. | 29.5 ± 17 | 0.187 | 29.4 ± 17 | 0.320 | 0.069 | 29.7 ± 17 | 0.211 | ||||||||
Compl. | 25 ± 10 | 25.1 ± 13 | 25.7 ± 15 | |||||||||||||
216 | PAC | 26.7% | 0.074 | 6.7% | 0.421 | 5.9% | 0.435 | 0.403 | 16.2% | 0.092 | 69.8 ± 183 | 0.094 | ||||
NPC | 37.0% | 4.9% | 7.4% | 25.7% | 83.5 ± 127 | |||||||||||
187 | No compl. | 68.6 ± 175 | 0.333 | 72.3 ± 180 | -0.773 | 69.8 ± 183 | 0.640 | |||||||||
Compl. | 128.1 ± 199 | 62.5 ± 100 | 83.5 ± 127 | |||||||||||||
187 | < 7 | 0.529 | 35.6% | 0.033 | ||||||||||||
> 7 | 57.7% | |||||||||||||||
187 | No PF C | 0.318 | 0.818 | - | 0.464 | |||||||||||
PF C | ||||||||||||||||
187 | No PF B | 6.5% | 0.676 | 0.318 | 0.818 | 10.7% | - | 0.221 | ||||||||
PF B | 5.6% | 100% | ||||||||||||||
187 | No PF A | 0.148 | 0.171 | 0.734 | - | 0.141 | ||||||||||
PF A | ||||||||||||||||
187 | No PF B+C | 0.088 | 0.655 | |||||||||||||
PF B+C | 100% | |||||||||||||||
240 | P1 | 35.4% | 0.383 | 25.0% | 0.155 | 5.2% | 0.485 | 0.230 | 16.9% | 0.292 | 17.7 | 0.137 | ||||
P2 | 38.2% | 31.9% | 6.3% | 21.2% | 11.8 | |||||||||||
240 | 19.6 ± 13 | 0.075 | ||||||||||||||
29 ± 10 |
Type of all general complications (n = 240) | n | % | % 90-day mortality |
---|---|---|---|
No general complications | 202 | 84.2 | 5.0 |
Pneumonia | 8 | 3.3 | 25 |
Cardiorespiratory decompensation | 3 | 1.3 | 100 |
Heart failure | 9 | 3.8 | 11.1 |
Pulmonary embolism | 4 | 1.7 | 25 |
Different infections | 10 | 4.2 | 10 |
Renal failure | 1 | .4 | 100 |
Brain stroke | 1 | .4 | 0 |
Miscellaneous | 2 | .8 | 0 |
Indication for pancreatic resection | P1 | P2 | All | p |
---|---|---|---|---|
(n/ %) | (n/ %) | (n/ %) | ||
Pancreatic adeno carcinoma | 64 | 71 | 135 | |
66.7% | 50.0% | 56.7% | ||
Neuroendocrine tumor of the pancreas | 2 | 7 | 9 | |
2.1% | 4.9% | 3.8% | ||
Main duct intraductal papillary mucinous neoplasm | 0 | 3 | 3 | |
0.0% | 1.4% | 0.8% | ||
Franz’s tumor | 1 | 0 | 1 | |
1.0% | 0.0% | 0.4% | ||
Non-Hodgkin lymphoma of the pancreas | 1 | 1 | 2 | |
1.0% | 0.7% | 0.8% | ||
Adenocarcinoma of the distal bile duct | 13 | 30 | 43 | |
13.5% | 20.8% | 17.9% | ||
Adenocarcinoma of the papilla Vateri | 12 | 18 | 30 | |
12.5% | 12.5% | 12.5% | ||
Duodenal adenocarcinoma | 2 | 6 | 8 | |
2.1% | 4.2% | 3.3% | ||
Gastric cancer | 0 | 2 | 2 | |
0.0% | 1.4% | 0.8% | ||
Chronic pancreatitis | 1 | 6 | 7 | |
1.0% | 4.2% | 2.9% |